Your browser doesn't support javascript.
loading
Usefulness of switching to cabergoline from other dopamine agonists in patients with advanced Parkinson's disease.
Shiraishi, M; Kamo, T; Hotta, M; Nemoto, S; Oshima, J; Sugihara, H; Yasaki, S; Kawakami, M; Takahashi, Y; Shimojo, S.
Affiliation
  • Shiraishi M; Department of Neurology, St. Marianna University School of Medicine, Miyamae Ward, Kawasaki City, Japan. shira@marianna-u.ac.jp
J Neural Transm (Vienna) ; 111(6): 725-32, 2004 Jun.
Article in En | MEDLINE | ID: mdl-15168219
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Ergolines / Antiparkinson Agents Type of study: Observational_studies / Risk_factors_studies Limits: Aged / Humans Language: En Journal: J Neural Transm (Vienna) Year: 2004 Document type: Article Affiliation country: Japan Country of publication: Austria
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Ergolines / Antiparkinson Agents Type of study: Observational_studies / Risk_factors_studies Limits: Aged / Humans Language: En Journal: J Neural Transm (Vienna) Year: 2004 Document type: Article Affiliation country: Japan Country of publication: Austria